Clinical Trial Update: Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Transarterial Ethanol Ablation (TEA) with Transcatheter Arterial Chemoembolisation (TACE) for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Transarterial Ethanol Ablation
• Transcatheter Arterial Chemoembolisation

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED